Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bergmann

Showing results (231-240 of 254) with videos related to

Pageof 26
Sort By:
Frontiers in Microbiology|March 21, 2019
The Selection of a Hepatocyte Cell Line Susceptible to <i>Plasmodium falciparum</i> Sporozoite Invasion That Is Associated With Expression of Glypican-3Rebecca E Tweedell, Dingyin Tao, Timothy Hamerly, et al.
Frontiers in Bioengineering and Biotechnology|April 8, 2022
Blast Waves Cause Immune System Dysfunction and Transient Bone Marrow Failure in a Mouse ModelElke S Bergmann-Leitner, Alexander G Bobrov, Jessica S Bolton, et al.
Infection and Immunity|December 25, 2004
The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasitesChristian A Darko, Evelina Angov, William E Collins, et al.
Plos One|July 31, 2008
Protection induced by Plasmodium falciparum MSP1(42) is strain-specific, antigen and adjuvant dependent, and correlates with antibody responsesJeffrey A Lyon, Evelina Angov, Michael P Fay, et al.
Plos One|June 3, 2021
Serological profiles of pan-coronavirus-specific responses in COVID-19 patients using a multiplexed electro-chemiluminescence-based testing platformSidhartha Chaudhury, Jack Hutter, Jessica S Bolton, et al.
Vaccine|June 2, 2019
Safety, toxicity and immunogenicity of a malaria vaccine based on the circumsporozoite protein (FMP013) with the adjuvant army liposome formulation containing QS21 (ALFQ)Alicia Cawlfield, Christopher J Genito, Zoltan Beck, et al.
The Journal of Infectious Diseases|August 19, 2025
Vaccine-induced antibodies to a C-terminal Plasmodium falciparum circumsporozoite protein epitope are associated with protectionDeAnna J Friedman-Klabanoff, Travis L Jensen, Casey E Gelber, et al.
Multiple Sclerosis and Related Disorders|February 19, 2026
Using cognitive testing to predict employment status in multiple sclerosis: A comparative study of the SDMT and a computerized cognitive assessment toolDaija A Jackson, Catherine S Bergmann, Jeffrey Wilken, et al.
Science (New York, N.Y.)|May 4, 2019
Chromatin three-dimensional interactions mediate genetic effects on gene expressionO Delaneau, M Zazhytska, C Borel, et al.
The Journal of Infectious Diseases|February 8, 2024
Recombinant Full-length Plasmodium falciparum Circumsporozoite Protein-Based Vaccine Adjuvanted With Glucopyranosyl Lipid A-Liposome Quillaja saponaria 21: Results of Phase 1 Testing With Malaria ChallengeDeAnna J Friedman-Klabanoff, Andrea A Berry, Mark A Travassos, et al.
Pageof 26

Showing results (231-240 of 254) with videos related to

Sort By:
Pageof 26
Frontiers in Microbiology|March 21, 2019
The Selection of a Hepatocyte Cell Line Susceptible to <i>Plasmodium falciparum</i> Sporozoite Invasion That Is Associated With Expression of Glypican-3Rebecca E Tweedell, Dingyin Tao, Timothy Hamerly, et al.
Frontiers in Bioengineering and Biotechnology|April 8, 2022
Blast Waves Cause Immune System Dysfunction and Transient Bone Marrow Failure in a Mouse ModelElke S Bergmann-Leitner, Alexander G Bobrov, Jessica S Bolton, et al.
Infection and Immunity|December 25, 2004
The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasitesChristian A Darko, Evelina Angov, William E Collins, et al.
Plos One|July 31, 2008
Protection induced by Plasmodium falciparum MSP1(42) is strain-specific, antigen and adjuvant dependent, and correlates with antibody responsesJeffrey A Lyon, Evelina Angov, Michael P Fay, et al.
Plos One|June 3, 2021
Serological profiles of pan-coronavirus-specific responses in COVID-19 patients using a multiplexed electro-chemiluminescence-based testing platformSidhartha Chaudhury, Jack Hutter, Jessica S Bolton, et al.
Vaccine|June 2, 2019
Safety, toxicity and immunogenicity of a malaria vaccine based on the circumsporozoite protein (FMP013) with the adjuvant army liposome formulation containing QS21 (ALFQ)Alicia Cawlfield, Christopher J Genito, Zoltan Beck, et al.
The Journal of Infectious Diseases|August 19, 2025
Vaccine-induced antibodies to a C-terminal Plasmodium falciparum circumsporozoite protein epitope are associated with protectionDeAnna J Friedman-Klabanoff, Travis L Jensen, Casey E Gelber, et al.
Multiple Sclerosis and Related Disorders|February 19, 2026
Using cognitive testing to predict employment status in multiple sclerosis: A comparative study of the SDMT and a computerized cognitive assessment toolDaija A Jackson, Catherine S Bergmann, Jeffrey Wilken, et al.
Science (New York, N.Y.)|May 4, 2019
Chromatin three-dimensional interactions mediate genetic effects on gene expressionO Delaneau, M Zazhytska, C Borel, et al.
The Journal of Infectious Diseases|February 8, 2024
Recombinant Full-length Plasmodium falciparum Circumsporozoite Protein-Based Vaccine Adjuvanted With Glucopyranosyl Lipid A-Liposome Quillaja saponaria 21: Results of Phase 1 Testing With Malaria ChallengeDeAnna J Friedman-Klabanoff, Andrea A Berry, Mark A Travassos, et al.
Pageof 26